Literature DB >> 11762922

Three-step synthesis of (R)- and (S)-thalidomides from ornithine.

E Suzuki1, N Shibata.   

Abstract

Three-step synthesis of enantiomerically pure thalidomide is described. D-Ornithine (2) reacted with thionyl chloride in methanol followed by treatment with triethylamine to give the (R)-3-amino-piperidin-2-one hydrochloride (3) in good yield. Protection of amino moiety by the use of N-carboethoxyphtalimide in DMSO furnished (R)-N-phtaloylpiperidin-2-one (4) as colorless crystals. Finally, the oxidation using a catalytic amount of RuO2 in the presence of excess sodium metaperiodate in a two-phase system gave (R)-thalidomide (1) in good yield without racemization. (S)-Thalidomide (1) was also synthesized from L-ornithine (2) in good overall yield. Since all the intermediates to thalidomide are easily recrystallized, the present method can be performed on a large scale without purification by column chromatography.

Entities:  

Year:  2001        PMID: 11762922

Source DB:  PubMed          Journal:  Enantiomer        ISSN: 1024-2430


  4 in total

1.  Self-disproportionation of enantiomers of thalidomide and its fluorinated analogue via gravity-driven achiral chromatography: mechanistic rationale and implications.

Authors:  Mayaka Maeno; Etsuko Tokunaga; Takeshi Yamamoto; Toshiya Suzuki; Yoshiyuki Ogino; Emi Ito; Motoo Shiro; Toru Asahi; Norio Shibata
Journal:  Chem Sci       Date:  2014-10-30       Impact factor: 9.825

2.  Structural basis of thalidomide enantiomer binding to cereblon.

Authors:  Tomoyuki Mori; Takumi Ito; Shujie Liu; Hideki Ando; Satoshi Sakamoto; Yuki Yamaguchi; Etsuko Tokunaga; Norio Shibata; Hiroshi Handa; Toshio Hakoshima
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

3.  Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others.

Authors:  Etsuko Tokunaga; Hidehiko Akiyama; Vadim A Soloshonok; Yuki Inoue; Hideaki Hara; Norio Shibata
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

4.  Understanding the Thalidomide Chirality in Biological Processes by the Self-disproportionation of Enantiomers.

Authors:  Etsuko Tokunaga; Takeshi Yamamoto; Emi Ito; Norio Shibata
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.